Hostname: page-component-745bb68f8f-s22k5 Total loading time: 0 Render date: 2025-02-11T23:59:38.943Z Has data issue: false hasContentIssue false

Varying temporal criteria for generalized anxiety disorder: prevalence and clinical characteristics in a young age cohort

Published online by Cambridge University Press:  31 May 2006

JULES ANGST
Affiliation:
Zurich University Psychiatric Hospital, Zurich, Switzerland
ALEX GAMMA
Affiliation:
Zurich University Psychiatric Hospital, Zurich, Switzerland
O. JOSEPH BIENVENU
Affiliation:
School of Medicine, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, MD, USA
WILLIAM W. EATON
Affiliation:
School of Public Health, Department of Mental Health, Johns Hopkins University, Baltimore, MD, USA
VLADETA AJDACIC
Affiliation:
Zurich University Psychiatric Hospital, Zurich, Switzerland
DOMINIQUE EICH
Affiliation:
Zurich University Psychiatric Hospital, Zurich, Switzerland
WULF RÖSSLER
Affiliation:
Zurich University Psychiatric Hospital, Zurich, Switzerland
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Background. This study questions the 6-month duration criterion for generalized anxiety disorder (GAD) used in DSM-III-R and DSM-IV.

Method. In adults from age 20/21 to 40/41 in the prospective Zurich Cohort Study, four groups of generalized anxiety syndromes defined by varying duration (2 weeks, 1 month, 3 months and 6 months) were compared.

Results. Applying DSM-III (1979–1999) and DSM-III-R (1986–1999) criteria, there were no significant differences between the four groups in terms of family history of anxiety, work impairment, distress, treatment rates or co-morbidity with major depressive episodes (MDEs), bipolar disorder or suicide attempts. Only social impairment related to the length of episodes. The 6-month criterion of DSM-III-R and DSM-IV GAD would preclude this diagnosis in about half of the subjects treated for generalized anxiety syndromes.

Conclusions. In this epidemiological sample, the 6-month duration criterion for GAD could not be confirmed as clinically meaningful. GAD syndromes of varying duration form a continuum with comparable clinical relevance.

Type
Original Article
Copyright
2006 Cambridge University Press